Literature DB >> 25064602

Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: implications for axonal transport.

Filipa I Baptista1, Maria J Pinto2, Filipe Elvas1, Tiago Martins1, Ramiro D Almeida3, António F Ambrósio4.   

Abstract

Diabetic retinopathy is a leading cause of vision loss and blindness. Disruption of axonal transport is associated with many neurodegenerative diseases and might also play a role in diabetes-associated disorders affecting nervous system. We investigated the impact of type 1 diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein motor proteins in the retina. Additionally, since hyperglycemia is considered the main trigger of diabetic complications, we investigated whether prolonged exposure to elevated glucose could affect the content and distribution of motor proteins in retinal cultures. The immunoreactivity of motor proteins was evaluated by immunohistochemistry in retinal sections and by immunoblotting in total retinal extracts from streptozotocin-induced diabetic and age-matched control animals. Primary retinal cultures were exposed to high glucose (30 mM) or mannitol (osmotic control; 24.5 mM plus 5.5 mM glucose), for seven days. Diabetes decreased the content of KIF1A at 8 weeks of diabetes as well as KIF1A immunoreactivity in the majority of retinal layers, except for the photoreceptor and outer nuclear layer. Changes in KIF5B immunoreactivity were also detected by immunohistochemistry in the retina at 8 weeks of diabetes, being increased at the photoreceptor and outer nuclear layer, and decreased in the ganglion cell layer. Regarding dynein immunoreactivity there was an increase in the ganglion cell layer after 8 weeks of diabetes. No changes were detected in retinal cultures. These alterations suggest that axonal transport may be impaired under diabetes, which might contribute to early signs of neural dysfunction in the retina of diabetic patients and animal models.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  axonal transport; diabetes; dynein; kinesin; retina

Mesh:

Substances:

Year:  2014        PMID: 25064602     DOI: 10.1016/j.exer.2014.07.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

Review 1.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

Review 2.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

3.  GSK-3β Phosphorylation of Cytoplasmic Dynein Reduces Ndel1 Binding to Intermediate Chains and Alters Dynein Motility.

Authors:  Feng J Gao; Sachin Hebbar; Xu A Gao; Michael Alexander; Jai P Pandey; Michael D Walla; William E Cotham; Stephen J King; Deanna S Smith
Journal:  Traffic       Date:  2015-06-26       Impact factor: 6.215

4.  Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features.

Authors:  Marzia Pesaresi; Silvia Giatti; Roberto Spezzano; Simone Romano; Silvia Diviccaro; Tiziana Borsello; Nico Mitro; Donatella Caruso; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  Biol Sex Differ       Date:  2018-01-19       Impact factor: 5.027

5.  Elevated Glucose and Interleukin-1β Differentially Affect Retinal Microglial Cell Proliferation.

Authors:  Filipa I Baptista; Célia A Aveleira; Áurea F Castilho; António F Ambrósio
Journal:  Mediators Inflamm       Date:  2017-05-15       Impact factor: 4.711

6.  Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF.

Authors:  Luís F Martins; Rui O Costa; Joana R Pedro; Paulo Aguiar; Sofia C Serra; Fabio G Teixeira; Nuno Sousa; António J Salgado; Ramiro D Almeida
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

7.  Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes.

Authors:  Mariana R P Alves; Raquel Boia; Elisa J Campos; João Martins; Sara Nunes; Maria H Madeira; Ana Raquel Santiago; Frederico C Pereira; Flávio Reis; António F Ambrósio; Filipa I Baptista
Journal:  Mol Vis       Date:  2018-05-18       Impact factor: 2.367

8.  The proteasome controls presynaptic differentiation through modulation of an on-site pool of polyubiquitinated conjugates.

Authors:  Maria J Pinto; Pedro L Alves; Luís Martins; Joana R Pedro; Hyun R Ryu; Noo Li Jeon; Anne M Taylor; Ramiro D Almeida
Journal:  J Cell Biol       Date:  2016-03-28       Impact factor: 10.539

Review 9.  Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.

Authors:  Cristina Hernández; Massimo Dal Monte; Rafael Simó; Giovanni Casini
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

10.  Blockade of microglial adenosine A2A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells.

Authors:  Inês Dinis Aires; Raquel Boia; Ana Catarina Rodrigues-Neves; Maria Helena Madeira; Carla Marques; António Francisco Ambrósio; Ana Raquel Santiago
Journal:  Glia       Date:  2019-01-22       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.